gliquidone has been researched along with gliclazide in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ambrosi, F; Cristallini, S; Filipponi, P; Gregorio, F; Pedetti, M; Santeusanio, F | 1 |
| Altomare, E; Di Reda, N; Giovine, A; Lasorsa, G; Procacci, V; Roberto, MG; Stufano, N; Vendemiale, G | 1 |
| Harrower, AD | 1 |
| Akkan, AG; Malaisse, WJ; Sener, A | 1 |
| Bresler, M; Grzeszczak, W; Gumprecht, J; Strojek, K; Trautsolt, W | 1 |
| König, E; Limmer, J; Rupprecht, E | 1 |
| Grzeszczak, W; Strojek, K | 1 |
| Selvaag, E | 1 |
| Bataille, D; Blache, P; Gros, L; Salazar, G; Virsolvy, A | 1 |
| Courtois, P; Herbaut, C; Malaisse, WJ; Sener, A; Turc, A | 1 |
| Jin, SH; Li, ZR; Shi, YQ; Yao, J | 1 |
| Binz, TM; Neels, H; Schneider, S; Villani, N | 1 |
| Cao, J; Jiang, Q; Li, H; Li, R; Xu, Q | 1 |
1 trial(s) available for gliquidone and gliclazide
| Article | Year |
|---|---|
Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.
Topics: Aged; Chlorpropamide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
14 other study(ies) available for gliquidone and gliclazide
| Article | Year |
|---|---|
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
Topics: Animals; Blood Glucose; Dose-Response Relationship, Drug; Gliclazide; Glucagon; Glucose; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Perfusion; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1992 |
[Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus].
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gliclazide; Glucose; Humans; Hypoglycemic Agents; Insulin; Middle Aged; Sulfonylurea Compounds | 1988 |
Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma.
Topics: Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drug Monitoring; Forensic Medicine; Gliclazide; Glipizide; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Reproducibility of Results; Sensitivity and Specificity; Sulfonylurea Compounds | 1995 |
[Does hypoglycemic treatment with gliclazide and gliquidone affect platelet function in type II diabetic patients?].
Topics: Adult; Aged; Blood Platelets; Diabetes Mellitus, Type 2; Gliclazide; Humans; Hypoglycemic Agents; Middle Aged; Reference Values; Sulfonylurea Compounds | 1993 |
[Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
Topics: Diabetes Mellitus, Type 2; Gliclazide; Glyburide; Humans; Hypoglycemic Agents; Sulfonylurea Compounds | 1993 |
[Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Gliclazide; Humans; Hypoglycemic Agents; Middle Aged; Platelet Aggregation; Sulfonylurea Compounds | 1993 |
Photohemolytic potency of oral antidiabetic drugs in vitro: effects of antioxidants and a nitrogen atmosphere.
Topics: Antioxidants; Ascorbic Acid; Carbutamide; Chlorpropamide; Dose-Response Relationship, Drug; Gliclazide; Glipizide; Glyburide; Hemolysis; Humans; Hypoglycemic Agents; Nitrogen; Radiation-Sensitizing Agents; Reactive Oxygen Species; Sulfonamides; Sulfonylurea Compounds; Superoxide Dismutase; Tolazamide; Tolbutamide; Ultraviolet Rays; Vitamin E | 1996 |
Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
Topics: Animals; ATP-Binding Cassette Transporters; Binding Sites; Blotting, Northern; Cell Line; Cell Membrane; COS Cells; Gliclazide; Glipizide; Glyburide; Islets of Langerhans; Kinetics; Organelles; Phentolamine; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Receptors, Drug; Recombinant Fusion Proteins; Sulfonylurea Compounds; Sulfonylurea Receptors; Tolbutamide; Transfection | 1999 |
Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects.
Topics: Aged; Female; Gliclazide; Glipizide; Glyburide; Half-Life; Humans; Hypoglycemic Agents; Male; Middle Aged; Sulfonylurea Compounds | 1999 |
Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs.
Topics: Carbamates; Chromatography, High Pressure Liquid; Gliclazide; Glipizide; Glyburide; Hypoglycemic Agents; Molecular Structure; Piperidines; Reproducibility of Results; Sulfonylurea Compounds | 2007 |
Rapid extraction, identification and quantification of oral hypoglycaemic drugs in serum and hair using LC-MS/MS.
Topics: Acetonitriles; Chromatography, Liquid; Female; Forensic Toxicology; Gliclazide; Glipizide; Glyburide; Hair; Humans; Hypoglycemic Agents; Limit of Detection; Male; Mass Spectrometry; Metformin; Methanol; Middle Aged; Molecular Structure; Solvents; Sulfonylurea Compounds | 2012 |
Nanofibers mat as sampling module of direct analysis in real time mass spectrometry for sensitive and high-throughput screening of illegally adulterated sulfonylureas in antidiabetic health-care teas.
Topics: Acrylic Resins; Allyl Compounds; Food Contamination; Gliclazide; Hypoglycemic Agents; Imidazoles; Ionic Liquids; Mass Spectrometry; Nanofibers; Solid Phase Extraction; Sulfonylurea Compounds; Tea | 2019 |